Aktieselskabet Schouw & Co.
5.10.2026 15:30:00 CEST | Globenewswire | Press release
Schouw & Co. share buy-back programme, week 40 2026
Schouw & Co. share buy-back programme, week 40 2026
Schouw & Co. share buy-back programme, week 40 2026
On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
| Trading day | No. of shares | Average price | Amount DKK | ||
| Accumulated until 25 September 2026 | 470,041 | 705.04 | 331,398,272 | ||
| Monday, 28 September 2026 | 5,900 | 813.00 | 4,796,700 | ||
| Tuesday, 29 September 2026 | 5,500 | 807.27 | 4,440,000 | ||
| Wednesday, 30 September 2026 | 5,000 | 804.50 | 4,022,500 | ||
| Thursday, 1 October 2026 | 5,000 | 790.21 | 3,951,027 | ||
| Friday, 2 October 2026 | 5,000 | 799.04 | 3,995,208 | ||
| In the period 28 September 2026 - 2 October 2026 | 26,400 | 803.24 | 21,205,435 | ||
| Accumulated until 2 October 2026 | 496,441 | 710.26 | 352,603,707 | ||
| Following the above transactions, Schouw & Co. holds a total of 2,794,234 treasury shares corresponding to 11.18% of the total share capital of 25,000,000 shares. | |||||
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma5.10.2026 18:30:00 CEST | Press release
Zealand Pharma – Completion of share buy-back program and related transactions (week 40 and 41, 2026)
Optica5.10.2026 18:13:09 CEST | Press release
Three Researchers Awarded 2026 Nobel Prize in Physiology or Medicine for Their Pioneering Contributions to Optogenetics
Poppulo5.10.2026 17:59:36 CEST | Press release
Poppulo Named a Challenger in the 2026 Gartner® Magic Quadrant™ for Intranet Packaged Solutions
Idorsia Pharmaceuticals Ltd5.10.2026 17:45:00 CEST | Press release
Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension
Sironax USA, Inc.5.10.2026 17:00:00 CEST | Press release
Sironax Named to Fierce Biotech’s “Fierce 15” List of the Most Innovative and Promising Private Biotechs of 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom